THE EFFECTS OF HIGH DOSE PRAVASTATIN AND LOW DOSE PRAVASTATIN AND EZETIMIBE COMBINATION THERAPY ON LIPID, GLUCOSE METABOLISM AND INFLAMMATION

Basit Öğe Kaydı
dc.contributor.authorDagli, N.
dc.contributor.authorKaraca, I.
dc.contributor.authorYavuzkir, M.
dc.date.accessioned2026-08-12T17:01:46Z
dc.date.issued2008
dc.departmentFırat Üniversitesi
dc.description.abstract[Abstract Not Available]
dc.identifier.doi10.1016/S1567-5688(08)70746-3
dc.identifier.endpage186
dc.identifier.issn1567-5688
dc.identifier.issue1
dc.identifier.startpage186
dc.identifier.urihttps://doi.org/10.1016/S1567-5688(08)70746-3
dc.identifier.urihttps://hdl.handle.net/11508/47867
dc.identifier.volume9
dc.identifier.wosWOS:000207610701465
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherElsevier Ireland Ltd
dc.relation.ispartofAtherosclerosis Supplements
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.titleTHE EFFECTS OF HIGH DOSE PRAVASTATIN AND LOW DOSE PRAVASTATIN AND EZETIMIBE COMBINATION THERAPY ON LIPID, GLUCOSE METABOLISM AND INFLAMMATION
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu